Skip to main content
Clinical Trials/NCT02449512
NCT02449512
Withdrawn
Not Applicable

Somatosensory Evoked Potentials From the Lower Urinary Tract in Individuals With Neurogenic Lower Urinary Tract Dysfunction as a Result of Spinal Cord Injury

Swiss Paraplegic Research, Nottwil1 site in 1 country24 target enrollmentJanuary 1, 2026

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neurogenic Lower Urinary Tract Dysfunction
Sponsor
Swiss Paraplegic Research, Nottwil
Enrollment
24
Locations
1
Primary Endpoint
occurrence of somatosensory evoked potentials from the bladder
Status
Withdrawn
Last Updated
9 months ago

Overview

Brief Summary

Spinal cord injury and other systemic neurological diseases (Multiple Sclerosis, Parkinson's disease) affect the integrity of lower urinary tract (LUT) function, leading to neurogenic lower urinary tract dysfunction (NLUTD). The urodynamic investigation is the current "gold-standard" for evaluating LUT function. Nevertheless, the sensory situation of the LUT cannot be investigated objectively. Furthermore, the current classification of the severity of the NLUTD due to spinal cord injury (SCI) does not represent the sensory situation of the LUT. Additional investigations therefore need to be established for assessing the sensory situation of the LUT. Somatosensory evoked potentials (SEPs) are an established method for investigating the processing of sensory nervous activity. However, SEPs from the LUT of SCI individuals have not yet been investigated.

A novel technique, i.e. diffusion tensor imaging (DTI), allows to process magnetic resonance images (MRI) in order to visualize nerve fibers. Using DTI, the innervation of the bladder after SCI can be visualized. The structural presentation of bladder innervation will be compared with the functional results, i.e. the SEP of the LUT in SCI individuals.

The primary objective of the proposed study is to elicit and characterize (latency, amplitude) the somatosensory evoked potentials (SEPs) from the bladder in individuals suffering from neurogenic lower urinary tract dysfunction as a result of spinal cord injury.

Furthermore, the SEPs from the bladder will be compared with the SEPs from peripheral nerves (N. tibialis, N. pudendus, N. medianus).

Moreover, the latency and amplitude of the SEPs from the bladder of individuals with somato-sensory complete spinal cord injury will be compared with those from the bladder of individuals with somato-sensory incomplete spinal cord injury.

Finally, the structural innervation of the bladder after SCI will be compared with the remaining sensory function.

Registry
clinicaltrials.gov
Start Date
January 1, 2026
End Date
December 1, 2028
Last Updated
9 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Swiss Paraplegic Research, Nottwil
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Informed Consent as documented by signature
  • Chronic SCI of a minimum of 1 year
  • Aetiology of SCI: traumatic

Exclusion Criteria

  • Age \< 18 years or \> 70 years
  • Aetiology of SCI: non-traumatic
  • History of bleeding disorder
  • History of chronic neuropathic pain
  • Intravesical botulinum toxin injections \< 12 months ago
  • Bladder management using indwelling catheters (suprapubic, transurethral)
  • Bladder augmentation
  • Sacral deafferentation
  • Sacral neuromodulation
  • Acute, symptomatic urinary tract infection

Outcomes

Primary Outcomes

occurrence of somatosensory evoked potentials from the bladder

Time Frame: within 1 week after enrollment into study

Secondary Outcomes

  • peak-to-peak amplitude of somatosensory evoked potentials(within 1 week after enrollment into study)
  • nerve fiber density around bladder(within 1 week after enrollment into study)
  • fractional anisotropy of nerve fibers around bladder(within 1 week after enrollment into study)
  • latency of somatosensory evoked potentials(within 1 week after enrollment into study)
  • apparent diffusion coefficient of nerve fibers around bladder(within 1 week after enrollment into study)

Study Sites (1)

Loading locations...

Similar Trials